Recent Finacing
Recent Raise
Acumen Pharmaceuticals is a clinical-stage biopharma developing ACU193, an antibody targeting soluble amyloid-beta oligomers for Alzheimer’s and advancing a subcutaneous formulation into Phase 1 studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at Acumen Pharmaceuticals.
